← Back to Search

Observational for Renal Cell Carcinoma

N/A
Recruiting
Led By John C. Cheville, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (at enrollment)
Awards & highlights

Study Summary

This study is being done to collect blood, tissue and urine samples to identify a novel high quality methylated DNA marker in patients with renal tumors.

Eligible Conditions
  • Renal Cell Carcinoma
  • Kidney Cell Carcinoma
  • Kidney Cancer
  • Kidney Oncocytoma
  • Bladder Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (at enrollment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (at enrollment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Identify novel methylated DNA markers in tissue for malignant renal and urothelial tumors

Trial Design

1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Participants may undergo blood, urine, and tissue sample collection on study. Participants' medical records are also reviewed.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,221 Previous Clinical Trials
3,768,266 Total Patients Enrolled
John C. Cheville, M.D.Principal InvestigatorMayo Clinic in Rochester

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study
2018. "Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06339138.
All > Paid Studies Minneapolis
~261 spots leftby Jan 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top